Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia

Neurobiology of Disease

Volumn 21, Issue 3, 2006, Pages 657-668

  Carlsson, Thomas ^a   Winkler, Christian ^a,b   Lundblad, Martin ^a   Cenci, M Angela ^a   Björklund, Anders ^a   Kirik, Deniz ^a  

^a LUND UNIVERSITY   (Sweden)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cell transplantation; Dyskinesia; L DOPA; Motor behavior; Parkinson's disease; Ventral mesenchephalon

Indexed keywords

AMPHETAMINE; LEVODOPA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL TRANSPLANTATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DISEASE MODEL; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; DYSKINESIA; FEMALE; FETUS CELL; HYPERKINESIA; INVOLUNTARY MOVEMENT; LIMB; MESENCEPHALON; MOTOR DYSFUNCTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; RAT; REINNERVATION; TONGUE;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; DYSKINESIAS; FEMALE; FETAL TISSUE TRANSPLANTATION; LEVODOPA; MESENCEPHALON; NERVE REGENERATION; NEURONS; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33244459813     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2005.09.008     Document Type: Article

References (42)

1. M. Andersson, A. Hilbertson, and M.A. Cenci Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease Neurobiol. Dis. 6 1999 461 474
2. L.L. Brown, and F.R. Sharp Metabolic mapping of rat striatum: somatotopic organization of sensorimotor activity Brain Res. 686 1995 207 222
3. P. Brundin, O. Pogarell, P. Hagell, P. Piccini, H. Widner, A. Schrag, A. Kupsch, L. Crabb, P. Odin, B. Gustavii, A. Bjorklund, D.J. Brooks, C.D. Marsden, W.H. Oertel, N.P. Quinn, S. Rehncrona, and O. Lindvall Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease Brain. 123 Pt. 7 2000 1380 1390
4. J.J. Canales, G. Gilmour, and S.D. Iversen The role of nigral and thalamic output pathways in the expression of oral stereotypies induced by amphetamine injections into the striatum Brain Res. 856 2000 176 183
5. T. Carlsson, C. Winkler, C. Burger, N. Muzyczka, R.J. Mandel, A. Cenci, A. Bjorklund, and D. Kirik Reversal of dyskinesias in an animal model of Parkinson's disease by continuous l-DOPA delivery using rAAV vectors Brain 128 2005 559 569
6. M.A. Cenci, P. Kalen, R.J. Mandel, K. Wictorin, and A. Bjorklund Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum Neuroscience 46 1992 943 957
7. M.A. Cenci, K. Campbell, and A. Bjorklund Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels Neuroscience 57 1993 275 296
8. M.A. Cenci, C.S. Lee, and A. Bjorklund l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA Eur. J. Neurosci. 10 1998 2694 2706
9. M. Chritin, M. Savasta, F. Mennicken, A. Bal, D.N. Abrous, M. Le Moal, C. Feuerstein, and J.P. Herman Intrastriatal dopamine-rich implants reverse the increase of dopamine D2 receptor mRNA levels caused by lesion of the nigrostriatal pathway: a quantitative in situ hybridization study Eur. J. Neurosci. 4 1992 663 672
10. G.L. Defer, C. Geny, F. Ricolfi, G. Fenelon, J.C. Monfort, P. Remy, G. Villafane, R. Jeny, Y. Samson, Y. Keravel, A. Gaston, J.D. Degos, M. Peschanski, P. Cesaro, and J.P. Nguyen Long-term outcome of unilaterally transplanted parkinsonian patients: I. Clinical approach Brain 119 Pt. 1 1996 41 50
11. W.M. Duan, H. Widner, E.M. Frodl, and P. Brundin Immune reactions following systemic immunization prior or subsequent to intrastriatal transplantation of allogeneic mesencephalic tissue in adult rats Neuroscience 64 1995 629 641
12. A. Ebrahimi, R. Pochet, and M. Roger Topographical organization of the projections from physiologically identified areas of the motor cortex to the striatum in the rat Neurosci. Res. 14 1992 39 60
13. S. Fahn The spectrum of levodopa-induced dyskinesias Ann. Neurol. 47 2000 S2 S9 discussion S9-11
14. C.R. Freed, P.E. Greene, R.E. Breeze, W.Y. Tsai, W. DuMouchel, R. Kao, S. Dillon, H. Winfield, S. Culver, J.Q. Trojanowski, D. Eidelberg, and S. Fahn Transplantation of embryonic dopamine neurons for severe Parkinson's disease N. Engl. J. Med. 344 2001 710 719
15. C.R. Freed, R.E. Breeze, S. Fahn, and D. Eidelberg Preoperative response to levodopa is the best predictor of transplant outcome Ann. Neurol. 55 2004 896 author reply 896-897
16. B. Georgievska, T. Carlsson, B. Lacar, C. Winkler, and D. Kirik Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor Eur. J. Neurosci. 20 2004 3121 3130
17. P.E. Greene, S. Fahn, W.Y. Tsai, R.E. Breeze, D. Eidelberg, H. Winfield, S. Dillon, R. Kao, L. Winfield, and C.R. Freed Severe spontaneous dyskinesias: a disabling complication of embryonic dopaminergic tissue implants in a subset of transplanted patients with advanced Parkinson's disease Mov. Disord. 14 1999 904
18. P. Hagell, A. Schrag, P. Piccini, M. Jahanshahi, R. Brown, S. Rehncrona, H. Widner, P. Brundin, J.C. Rothwell, P. Odin, G.K. Wenning, P. Morrish, B. Gustavii, A. Bjorklund, D.J. Brooks, C.D. Marsden, N.P. Quinn, and O. Lindvall Sequential bilateral transplantation in Parkinson's disease: effects of the second graft Brain 122 Pt. 6 1999 1121 1132
19. P. Hagell, P. Piccini, A. Bjorklund, P. Brundin, S. Rehncrona, H. Widner, L. Crabb, N. Pavese, W.H. Oertel, N. Quinn, D.J. Brooks, and O. Lindvall Dyskinesias following neural transplantation in Parkinson's disease Nat. Neurosci. 5 2002 627 628
20. R.A. Hauser, T.B. Freeman, B.J. Snow, M. Nauert, L. Gauger, J.H. Kordower, and C.W. Olanow Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease Arch. Neurol. 56 1999 179 187
21. P. Jenner Factors influencing the onset and persistence of dyskinesia in MPTP-treated primates Ann. Neurol. 47 2000 S90 S99 discussion S99-S104
22. A.E. Kelley, C.G. Lang, and A.M. Gauthier Induction of oral stereotypy following amphetamine microinjection into a discrete subregion of the striatum Psychopharmacology (Berlin) 95 1988 556 559
23. D. Kirik, C. Winkler, and A. Bjorklund Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration J. Neurosci. 21 2001 2889 2896
24. R. Kuczenski, and D.S. Segal Sensitization of amphetamine-induced stereotyped behaviors during the acute response J. Pharmacol. Exp. Ther. 288 1999 699 709
25. C.S. Lee, M.A. Cenci, M. Schulzer, and A. Bjorklund Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease Brain 123 Pt. 7 2000 1365 1379
26. O. Lindvall, and A. Bjorklund Cell replacement therapy: helping the brain to repair itself NeuroRx 1 2004 379 381
27. M. Lundblad, M. Andersson, C. Winkler, D. Kirik, N. Wierup, and M.A. Cenci Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease Eur. J. Neurosci. 15 2002 120 132
28. Y. Ma, A. Feigin, V. Dhawan, M. Fukuda, Q. Shi, P. Greene, R. Breeze, S. Fahn, C. Freed, and D. Eidelberg Dyskinesia after fetal cell transplantation for parkinsonism: a PET study Ann. Neurol. 52 2002 628 634
29. C.D. Marsden, J.D. Parkes, and N. Quinn Fluctuations of disability in Parkinson's disease-Clinical aspects C.D. Marsden S. Fahn Disorders 1982 Butterworth London 96 122
30. G. Nikkhah, M. Olsson, J. Eberhard, C. Bentlage, M.G. Cunningham, and A. Bjorklund A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology Neuroscience 63 1994 57 72
31. J.G. Nutt, J.A. Obeso, and F. Stocchi Continuous dopamine-receptor stimulation in advanced Parkinson's disease Trends Neurosci. 23 2000 S109 S115
32. C.W. Olanow, C.G. Goetz, J.H. Kordower, A.J. Stoessl, V. Sossi, M.F. Brin, K.M. Shannon, G.M. Nauert, D.P. Perl, J. Godbold, and T.B. Freeman A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease Ann. Neurol. 54 2003 403 414
33. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1998 Academic Press San Diego
34. N.P. Quinn Classification of fluctuations in patients with Parkinson's disease Neurology 51 1998 S25 S29
35. M. Savasta, F. Mennicken, M. Chritin, D.N. Abrous, C. Feuerstein, M. Le Moal, and J.P. Herman Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study Neuroscience 46 1992 729 738
36. M. Shinoda, J.L. Hudson, I. Stromberg, B.J. Hoffer, J.W. Moorhead, and L. Olson Microglial cell responses to fetal ventral mesencephalic tissue grafting and to active and adoptive immunizations Exp. Neurol. 141 1996 173 180
37. K. Steece-Collier, T.J. Collier, P.D. Danielson, R. Kurlan, D.M. Yurek, and J.R. Sladek Jr. Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in parkinsonian rats Mov. Disord. 18 2003 1442 1454
38. I. Stromberg, J. Kehr, B. Andbjer, and K. Fuxe Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum Exp. Neurol. 164 2000 154 165
39. M.J. West Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias Trends Neurosci. 22 1999 51 61
40. C. Winkler, C. Bentlage, G. Nikkhah, M. Samii, and A. Bjorklund Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants Exp. Neurol. 155 1999 165 186
41. C. Winkler, D. Kirik, A. Bjorklund, and M.A. Cenci l-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson's disease: relation to motor and cellular parameters of nigrostriatal function Neurobiol. Dis. 10 2002 165 186
42. C. Winkler, D. Kirik, and A. Bjorklund Cell transplantation in Parkinson's disease: how can we make it work? Trends Neurosci. 28 2005 86 92